Enveric Biosciences, Inc. (ENVB)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 6.72M |
| Enterprise Value | -350.37k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.44 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.02 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.58 |
| 52-Week Change 3 | -45.12% |
| S&P500 52-Week Change 3 | 21.83% |
| 52 Week High 3 | 6.9800 |
| 52 Week Low 3 | 0.6490 |
| 50-Day Moving Average 3 | 1.0370 |
| 200-Day Moving Average 3 | 1.7383 |
Share Statistics
| Avg Vol (3 month) 3 | 4.44M |
| Avg Vol (10 day) 3 | 345.04k |
| Shares Outstanding 5 | 7.29M |
| Implied Shares Outstanding 6 | 7.29M |
| Float 8 | 7.17M |
| % Held by Insiders 1 | 7.06% |
| % Held by Institutions 1 | 6.71% |
| Shares Short (Mar 28, 2024) 4 | 254.87k |
| Short Ratio (Mar 28, 2024) 4 | 0.02 |
| Short % of Float (Mar 28, 2024) 4 | 3.51% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 3.49% |
| Shares Short (prior month Feb 29, 2024) 4 | 95.06k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Nov 25, 2019 |
| Ex-Dividend Date 4 | Apr 23, 2008 |
| Last Split Factor 2 | 1:50 |
| Last Split Date 3 | Jul 15, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -86.20% |
| Return on Equity (ttm) | -197.47% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -16.1M |
| Net Income Avi to Common (ttm) | -17.46M |
| Diluted EPS (ttm) | -8.0900 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.29M |
| Total Cash Per Share (mrq) | 0.31 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.53 |
| Book Value Per Share (mrq) | 0.71 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14.09M |
| Levered Free Cash Flow (ttm) | -9.9M |
© 2024 Yahoo. All rights reserved.